Literature DB >> 11884435

Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice.

Sabine Middendorp1, Gemma M Dingjan, Rudolf W Hendriks.   

Abstract

Bruton's tyrosine kinase (Btk) is a cytoplasmic signaling molecule that is crucial for precursor (pre-B) cell differentiation in humans. In this study, we show that during the transition of large cycling to small resting pre-B cells in the mouse, Btk-deficient cells failed to efficiently modulate the expression of CD43, surrogate L chain, CD2, and CD25. In an analysis of the kinetics of pre-B cell differentiation in vivo, Btk-deficient cells manifested a specific developmental delay within the small pre-B cell compartment of about 3 h, when compared with wild-type cells. Likewise, in in vitro bone marrow cultures, Btk-deficient large cycling pre-B cells showed increased IL-7 mediated expansion and reduced developmental progression into noncycling CD2(+)CD25(+) surrogate L chain-negative small pre-B cells and subsequently into Ig-positive B cells. Furthermore, the absence of Btk resulted in increased proliferative responses to IL-7 in recombination-activating gene-1-deficient pro-B cells. These findings identify a novel role for Btk in the regulation of the differentiation stage-specific modulation of IL-7 responsiveness in pro-B and pre-B cells. Moreover, our results show that Btk is critical for an efficient transit through the small pre-B cell compartment, thereby regulating cell surface phenotype changes during the developmental progression of cytoplasmic mu H chain expressing pre-B cells into immature IgM(+) B cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884435     DOI: 10.4049/jimmunol.168.6.2695

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state.

Authors:  Sebastian Königsberger; Jan Prodöhl; David Stegner; Vanessa Weis; Martin Andreas; Martin Stehling; Theresa Schumacher; Ruben Böhmer; Ina Thielmann; Judith M M van Eeuwijk; Bernhard Nieswandt; Friedemann Kiefer
Journal:  EMBO J       Date:  2012-06-22       Impact factor: 11.598

2.  Generation of heavy-chain-only antibodies in mice.

Authors:  Rick Janssens; Sylvia Dekker; Rudi W Hendriks; George Panayotou; Alexandra van Remoortere; John Kong-a San; Frank Grosveld; Dubravka Drabek
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

3.  Role of B cells in host defense against primary Coxiella burnetii infection.

Authors:  Laura Schoenlaub; Alexandra Elliott; Danielle Freches; William J Mitchell; Guoquan Zhang
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

4.  Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis.

Authors:  Renren Wen; Yuhong Chen; Li Bai; Guoping Fu; James Schuman; Xuezhi Dai; Hu Zeng; Chunying Yang; Robert P Stephan; John L Cleveland; Demin Wang
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

Review 5.  The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.

Authors:  Leslie J Crofford; Lindsay E Nyhoff; Jonathan H Sheehan; Peggy L Kendall
Journal:  Expert Rev Clin Immunol       Date:  2016-03-04       Impact factor: 4.473

6.  Core fucosylation of μ heavy chains regulates assembly and intracellular signaling of precursor B cell receptors.

Authors:  Wenzhe Li; Qingping Liu; Yue Pang; Jinhua Jin; Huiguo Wang; Hongyu Cao; Zhi Li; Xu Wang; Biao Ma; Yan Chi; Renjun Wang; Akihiro Kondo; Jianguo Gu; Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

7.  The pre-B-cell receptor induces silencing of VpreB and lambda5 transcription.

Authors:  Mathew J Parker; Steve Licence; Lena Erlandsson; Gunther R Galler; Lyubomira Chakalova; Cameron S Osborne; Geoff Morgan; Peter Fraser; Hassan Jumaa; Thomas H Winkler; Jane Skok; Inga-Lill Mårtensson
Journal:  EMBO J       Date:  2005-11-10       Impact factor: 11.598

Review 8.  Targeting Bruton's tyrosine kinase in B cell malignancies.

Authors:  Rudi W Hendriks; Saravanan Yuvaraj; Laurens P Kil
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

9.  Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.

Authors:  Jasper Rip; Marjolein J W de Bruijn; Stefan F H Neys; Simar Pal Singh; Jonas Willar; Jennifer A C van Hulst; Rudi W Hendriks; Odilia B J Corneth
Journal:  Eur J Immunol       Date:  2021-08-16       Impact factor: 6.688

10.  Btk expression is controlled by Oct and BOB.1/OBF.1.

Authors:  Cornelia Brunner; Thomas Wirth
Journal:  Nucleic Acids Res       Date:  2006-03-31       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.